Article information
Full text is only aviable in PDF
Bibliografía
[1.]
M.J. Strauss, D. Conrad, J.P. Logerfo, L.D. Hudson, M. Berrgner.
Cost and outcome of care for patients with chronic obstructive lung disease.
Analysis by physician speciality. Med Care, 24 (1986), pp. 915-924
[2.]
M. Decramer, R. Gooselink, T. Troosters, M. Vercshueren, G. Evers.
Muscle weakness is related to utilization of health care resources in COPD patients.
Eur Respir J, 10 (1997), pp. 417-423
[3.]
Intermitten Positive Pressure Breathing Trial Group.
Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease.
Ann Intern Med, 99 (1983), pp. 612-620
[4.]
M. Decramer, R. Gosselink, T. Troosters, R. Schepers.
Peripheral muscle weakness is associated with reduced survival in COPD [resumen].
Am J Respir Crit Care Med, 157 (1998), pp. A19
[5.]
M. Decramer, V. De Bock, D. Dom.
Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 153 (1996), pp. 1958-1964
[6.]
K.J. Killian, P. Leblanc, D.H. Martin, E. Summers, N.L. Jones, F.J.M. Campbell, et al.
Exercise capacity and ventilatory, circulatory, and sympton limitation in patients with chronic airflow limitation.
Am Rev Respir Dis, 146 (1992), pp. 935-940
[7.]
K. Wasserman, D.Y. Sue, R. Casaburi, R.B. Moricca.
Selection criteria for exercise training in pulmonary rehabilitation.
Eur Respir J, 7 (1989), pp. 604-610
[8.]
A. Grove, B.J. Lipworth, P. Reid, R.P. Smith, C.G. Ingram, R.J. Jenkins, et al.
Effects of regular salmeterol on long function and exercise capacity in patients with chronic obstructive pulmonari disease.
Thorax, 51 (1996), pp. 689-693
[9.]
D.E. Low, E.P. Trulock, L.R. Kaiser, M.K. Pasque, C. Dresler, N. Ettinger, et al.
Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema.
J Thora Cardiovasc Surg, 103 (1992), pp. 1119-1126
[10.]
R. Casaburi, Decconditioning.
Pulmonari rehabilitation., pp. 213-230
[11.]
American Thoracic Society/European Respiratory Society.
Skeletal muscle dysfunction in chronic obstructive pulmonary disease, 159 (1999), pp. S1-S40
[12.]
S. Tangri, C.R. Woolf.
The breathing pattern in chronic obstructive lung disease during performance of some common daily activities.
Chest, 63 (1973), pp. 126-127
[13.]
B.R. Celli, J. Rasulo, B.J. Make.
Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruction.
N Engl J Med, 314 (1986), pp. 1485-1490
[14.]
R. Banzett, G. Topulos, D.E. Leith, C. Natios.
Bracing arms increases the capacity for sustained hyperpnea.
Am Rev Respir Dis, 133 (1983), pp. 106-109
[15.]
R. Casaburi, T.J. Barstow, T. Robinson, K. Wasserman.
Dynamic and steady state ventilatory and gas exchange responses to arm exercise.
Med Sci Sports Exer, 24 (1992), pp. 1365-1374
[16.]
R. Gosselink, T. Trossters, M. Decramer.
Peripheral muscle weakness contributes to exercise limitation in COPD.
Am J Respir Crit Care Med, 153 (1996), pp. 976-980
[17.]
S. Bernard, P. Leblanc, F. Whittom, G. Carrier, J. Jobin, R. Belleau, et al.
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 158 (1998), pp. 629-634
[18.]
R. Gosselink, T. Troosters, M. Decramer.
Peripheral muscle weakness in upper and lower extremities in COPD patients.
Eur Respir J, 12 (1998), pp. S345
[19.]
A. Schols, R. Mostert, P.B. Soeters, E. Wouters.
Body composition and exercise performance in patients with chronic obstructive pulmonary disease.
Thorax, 46 (1991), pp. 695-699
[20.]
E.M. Baarends, A. Schols, R. Mostert, E. Wouters.
Peak exercise in relation to tissue depletion in patients with chronic obstructive pulmonary disease.
Eur Respir J, 10 (1997), pp. 2807-2813
[21.]
A.L. Hamilton, K.J. Killian, E. Summers, N.L. Jones.
Muscle strength, symptom intensity and exercise capacity in patients with cardiorespiratory disorders.
Am J Respir Crit Care Med, 152 (1995), pp. 2021-2031
[22.]
M. Decramer, L.M. Lacquet, R. Fagard, P. Rogiers.
Corticosteroids contribute to muscle weakness in chronic airflow obstruction.
Am Rev Respir Dis, 150 (1994), pp. 11-16
[23.]
T. Troosters, R. Gosselink, H. Rollier, M. Decramer.
Change in lower limb muscle strength contributes to altered six minute walking distance in COPD.
Eur Respir J, 9 (1996), pp. S144
[24.]
K. Simpson, K.J. Killian, N. McCartney, D.G. Stubbing, N.L. Jones.
Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation.
Thorax, 47 (1992), pp. 70-75
[25.]
M. Orozco-Levi, J. Gea, D. Maldonado.
Función de los músculos espiratorios en pacientes con EPOC: expresión de una miopía sistémica?.
Arch Bronconeumol, 34 (1998), pp. A58
[26.]
F. Maltais, A. Simard, C. Simard, J. Tobin, P. Desgagnés, P. Le Blanc.
Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD.
Am J Respir Crit Care Med, 153 (1996), pp. 288-293
[27.]
R. Casaburi, A. Patessio, F. Ioli, S. Zanaboni, C.F. Donner, K. Wasserman.
Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease.
Am Rev Respir Dis, 143 (1991), pp. 9-18
[28.]
A. Patessio, R. Casaburi, M. Carone, L. Appendini, C.F. Donner, K. Wasserman.
Comparison of gas exchange, lactate, and lactic acidosis thersholds in patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis, 148 (1993), pp. 622-626
[29.]
A.B. Evans, A.J. Al-Himyary, M.I. Hrovat, P. Pappagianopoulos, J.C. Wain, L.C. Ginns, et al.
Abnormal skeletal muscle oxidative capacity after lung transplantation by 31P-MRS.
Am J Respir Crit Care Med, 155 (1997), pp. 615-621
[30.]
A. Satta, G.B. Migliori, A. Spanevello, M. Neri, R. Bottinelli, M. Canepari, et al.
Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance.
Eur Respir J, 10 (1997), pp. 2853-2860
[31.]
F. Maltais, P. Leblanc, J. Simard, C. Jobin, J. Berubé, L. Bruneau, et al.
Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 154 (1996), pp. 442-447
[32.]
F. Maltais, P. Leblanc, J. Jobin, C. Berube, J. Bruneau, L. Carrier, et al.
Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 155 (1997), pp. 555-561
[33.]
C.J. Clark, J.E. Cochrane, E. Mackay.
Low intensity peripheral muscle conditioning improves exercise tolerance and brethlessness in COPD.
Eur Respir J, 9 (1996), pp. 2590-2596
[34.]
A. Schols, E. Wousters, P.B. Soeters, K.R. Westertep.
Body composition by bioelectrical impedance analysis compared to deterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease.
Am J Clin Nutr, 53 (1991), pp. 421-424
[35.]
B. Wuyam, J.F. Payen, P. Levy, H. Bensaidane, H. Reutenauer, J.F. Le Bas, et al.
Metabolism and anaerobic capacity of sleketal muscle in chronic respiratory failure related to chronic obstructive pulmonary diseaes.
Eur Respir J, 5 (1992), pp. 157-162
[36.]
C. Simard, F. Maltais, P. Leblanc, P.M. Simard, J. Jobin.
Mitochondrial and capillarity changes in vastus lateralis muscle of COPD patients: electron microscopy study.
Med Sci Sports Exerc, 28 (1996), pp. 95
[37.]
F. Whittom, J. Jobin, P.M. Simard, P. Leblanc, C. Simard, S. Bernard, et al.
Histochemical and morphological characteristics of the vastus lateralis muscle in COPD patients.
Med Sci Sports Exerc, 30 (1998), pp. 1467-1474
[38.]
R.L. Hughes, H. Katz, V. Sahgal, J.A. Campbell, R. Hartz, T.W. Shields.
Fiber size and energy metabolites in five separate muscles from patients with chronic obstructive lung disease.
Respiration, 44 (1983), pp. 321-328
[39.]
I.L. Hildebrand, C. Sylven, M. Esbjonrsson, K. Hellstrom, E. Jansson.
Does chronic hypoxaemia induce transformation of fibre types?.
Acta Physiol Scand, 141 (1991), pp. 435-439
[40.]
P. Jakobsson, L. Jordfelt, J. Henricksson.
Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 151 (1995), pp. 374-377
[41.]
F. Lundgren, A.G. Dahllof, T. Schersten, A.C. Bylund-Fellenius.
Muscle enzyme adaptation in patients with peripheral insufficiency: spontaneous adaptation, effect of different treatment and consequences on walking performance.
Clin Sci, 77 (1989), pp. 485-493
[42.]
Y. Sato, T. Asoh, Y. Honda, Y. Fujimatso, I. Higuchi, K. Oizumi.
Morphologic and histochemical evaluation of muscle in patients with chronic pulmonary emphysema manifesting generalized emaciation.
Eur Neurol, 37 (1997), pp. 116-121
[43.]
M. Pastó.
Función respiratoria.
proteínas estructurales y actividad enzimática en el diafragma [Tesis doctoral], Universidad Autónoma de Barcelona, (1988),
[44.]
M. Orozco-Levi, J. Gea, M. Aguar, J. Sauleda, J.M. Broquetas.
Adaptación estructural del diafragma en pacientes con enfermedad pulmonar obstructiva crónica.
Rev Colomb Neumol, 9 (1997), pp. 15-26
[46.]
M. Orozco-Levi, J. Gea.
Los músculos respiratorios: nuevos conceptos en anatomía, fisiología y su papel en la enfermedad pulmonar crónica.
Rev Colomb Neumol, 18 (1996), pp. 190-206
[47.]
D.F. Rochester, N.M.T. Braun, N.S. Arora.
Respiratory muscle strength in chronic obstructive pulmonary disease.
Am Rev Respir Dis, 119 (1979), pp. 151-154
[48.]
T. Similowsky, S. Yan, A.P. Gauthier, P.T. Macklem.
Contractile properties of the human diaphragm.
N Engl J Med, 325 (1991), pp. 917-923
[49.]
M. Orozco-Levi, J. Gea, J. Lloreta, M. Félez, J. Minguella, S. Serrano, et al.
Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease.
Eur Respir J, 13 (1999), pp. 371-378
[50.]
J. Lloreta, M. Orozco-Levi, J. Gea, K.M. Corominas, S. Serrano.
Selective diaphragmatic mitochondrial abnormalities in severe airflow obstruction.
Ultrastructural Pathology, 20 (1996), pp. 67-71
[51.]
M. Orozco-Levi, J. Gea, J. Lloreta, J. Minguella, J.M. Broquetas.
Changes in the capillary content of the diaphragm in COPD patients: a sort of muscle remodeling?.
Am J Respir Crit Care Med, 153 (1996), pp. A298
[52.]
M. Orozco-Levi, M.A. Jiménez, J. Gea, J.M. Corominas, J.M. Broquetas.
Capillary supply of the respiratory muscles in COPD.
Eur Respir J, 9 (1996), pp. 158
[53.]
R.L. Hughes, H. Katz, V. Sahgal, J.A. Campbell, R. Harz, T.W. Shields.
Fiber size and energy metabolites in five separate muscles from with chronic obstructive pulmonary disease.
Respiration, 44 (1983), pp. 321-323
[54.]
F. Levine, L. Kaiser, J. Leferovich, B. Tikunov.
Cellular adaptation in the diaphragm in chronic obstructive pulmonary disease.
N Engl J Med, 337 (1997), pp. 1799-1806
[55.]
Epstein SK. An overview of respiratory muscle function. En: Belman MJ, editor. Respiratory muscle dysfunction in neuromuscular disease. Clin Chest Med 1994; 15: 619-639.
[56.]
J. Sauleda, M. Orozco-Levi, J. Corominas, J. Minguella, M.C. Aguar, J. Broquetas, et al.
Structure and function relationships of the respiratory muscles.
Eur Respir J, 11 (1998), pp. 906-911
[57.]
M. Orozco-Levi, J. Gea, M.C. Aguar, J. Martín-Campos, J.M. Broquetas.
Changes in myosin expression in the external intercostal muscles of COPD patients.
Am J Respir Crit Care Med, 155 (1997), pp. A510
[58.]
M. Orozco-Levi, J. Gea, J. Monells, X. Arán, M.C. Aguar, J.M. Broquetas.
Activity of latissimus dorsi muscle during inspiratory thershold loads.
Eur Respir J, 8 (1995), pp. 441-445
[59.]
M. Orozco-Levi, J. Gea, J. Sauleda, J.M. Corominas, J. Minguella, X. Arán, et al.
Structure of the latissimus dorsi muscle respiratory function.
J Apply Physiol, 78 (1995), pp. 1132-1139
[60.]
M. Orozco-Levi, J. Gea, D. Maldonado.
Proposal for a threshold loading device for the assessment of expiratory muscle function in humans.
Am J Respir Crit Care Med, 155 (1997), pp. A518
[61.]
Ferrer A, Barreiro E, Hernández N, Mota S, Palacio J, Orozco- Levi M, et al. Cellular properties of the external oblique muscle and expiratory function in patients with severe COPD. Eur Respir J 1999 (en prensa).
[62.]
O. Pastoris, M. Dossena, P. Foppa, R. Arnaboldi, A. Gorini, R.F. Villa, et al.
Modifications by chronic intermittent hypoxia and drug treatment on skeletal muscle metabolism.
Neurochem Res, 20 (1995), pp. 143-150
[63.]
B. Triveldi, W.H. Danforth.
Effects of pH on the kinetics of frog muscle phosphofructokinase..
J Biol Chem, 10 (1966), pp. 4110-4114
[64.]
I. Gertz, G. Hedenstiema, G. Hellers, J. Wahren.
Muscle metabolism in patients with chronic obstructive lung disease and acute respiratory failure.
Clin Sci Mol Med, 52 (1977), pp. 395-403
[65.]
L. Kobzik, M.B. Reid, D.S. Bredt, J.S. Stamler.
Nitric oxide in skeletal muscle.
Nature, 372 (1994), pp. 546-548
[66.]
M. Buck, M. Chojkier.
Muscle wasting and dedifferentiation induced by oxidative stressin a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants..
EMBO J, 15 (1996), pp. 1753-1765
[67.]
M.J. Jackson, S. O’Farrel.
Free radicals and muscle damage.
Br Med Bull, 49 (1993), pp. 630-641
[68.]
H. Kondo, M. Miura, I. Nakagaki, S. Sasaki, Y. Itokawa.
Trace element movement and oxidative strees in skeletal muscle atrophied by immobilization.
Am J Physiol, 262 (1992), pp. E590-E593
[69.]
E.A. Flores, B.R. Bristain, J.J. Pomposelli, C.A. Dinarello, G.L. Blackburn, N.W. Istfan.
Infusion of tumor necrosis factor/cachectin promotes muscle metabolism in the rat..
J Clin Invest, 83 (1989), pp. 1614-1622
[70.]
M. Hall-Angeras, U. Angeras, O. Zamir, P.O. Hasselgren, J.E. Fischer.
Interaction between corticosterone and tumor necrosis factor simulated protein breakdown in rat skeletal muscle similar to sepsis.
Surgery, 108 (1990), pp. 460-466
[71.]
K.N. Jeejeebhoy.
How should we monitor nutritional support: structure or function?.
New Horiz, 2 (1994), pp. 131-138
[72.]
S.G. Kelsen, M. Ference, S. Kapoor.
Effects of prolonged undernutrition on structure and function of the diaphragm..
J Appl Physiol, 58 (1985), pp. 1354-1359
El presente artículo ha sido parcialmente subvencionado por BIOMED (ERESMUS in COPD).
Copyright © 2000. Sociedad Española de Neumología y Cirugía Torácica
